about
Identification of cytotoxic drugs that selectively target tumor cells with MYC overexpressionPharmacotherapy of neuroblastoma.Targeting p53-null neuroblastomas through RLIP76.N-Myc overexpression increases cisplatin resistance in neuroblastoma via deregulation of mitochondrial dynamics.Expression and significance of HER family receptors in neuroblastic tumors.
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
High-risk neuroblastoma: a therapy in evolution.
@en
High-risk neuroblastoma: a therapy in evolution.
@nl
type
label
High-risk neuroblastoma: a therapy in evolution.
@en
High-risk neuroblastoma: a therapy in evolution.
@nl
prefLabel
High-risk neuroblastoma: a therapy in evolution.
@en
High-risk neuroblastoma: a therapy in evolution.
@nl
P2860
P1476
High-risk neuroblastoma: a therapy in evolution.
@en
P2093
Abraham Fong
Julie R Park
P2860
P304
P356
10.3109/08880010903121173
P577
2009-11-01T00:00:00Z